ww@㎕w q򗝊w
publication
HOME
A
o[Љ
TvEւ̗U
Ɛ
犈
wEEfBAf
s
W
ANZX
 
wd_ۑuɂݍ̍ۓI狒_̌`v
 
 
 
Ɛ
z[>Ɛ>_iQOOXNj

_@iQOOXNj
  1. Ma L, Uchida H, Nagai J, Inoue M, Chun J, Aoki J and Ueda H.
    Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
    Molecular Pain. 5:64, 2009 Nov 13.
  2. Ma L, Matsumoto M, Xie W, Inoue M, Ueda H.
    Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist.
    J Neurochem. 109(2):603-610, 2009 Apr.
  3. Uchida H, Matsumoto M, Ueda H.
    Profiling of BoNT/C3-reversible gene expression induced by lysophosphatidic acid:ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia.
    Neurochem Int. 54(3-4):215-221, 2009 Mar-Apr.
  4. Fujita R, Ueda M, Fujiwara K, Ueda H.
    Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition.
    Cell Death Differ. 16(2):349-358, 2009 Feb.
  5. Matsushita Y, Ueda H.
    Curcumin blocks chronic morphine analgesic tolerance and BDNF up-regulation.
    Neuroreport. 7;20(1):63-68, 2009 Jan.
 
w
 
Copyright